Trials / Completed
CompletedNCT00438945
The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension
The Effect of Eprosartan in Patients With Essential Hypertension on Renal Tubular Function and Vasoactive Hormones During Baseline Conditions and After Activation of the Sympathetic Nervous System.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Regional Hospital Holstebro · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
We, the investigators at Holstebro Hospital, want to test the hypothesis that eprosartan reduces the activity of the sympathetic nervous system in patients with essential hypertension - during baseline conditions and after activation of the sympathetic nervous system.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Eprosartan |
Timeline
- Start date
- 2007-01-01
- Completion
- 2008-01-01
- First posted
- 2007-02-22
- Last updated
- 2008-05-09
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT00438945. Inclusion in this directory is not an endorsement.